Evaluation of the Effect of Oral Isotretinoin on the Level of Serum YKL40 in Acne Vulgaris Patients: A Cross-Sectional Case-Control.

Mahmoud Ahmed Ali Moustafa Adam El Taieb Eisa Mohamed HegazyHassan M IbrahimAlshimaa Abbas MohamedMohamed Amer Ahmed AbdellatifNour Mohammed AhmedAli Mohamed Younis

Published in: Clinical, cosmetic and investigational dermatology (2023)

The conclusion of this study was that reducing the blood levels of YKL-40 and the GAGS score in patients with acne vulgaris who took oral isotretinoin for three months was a crucial strategy.

Keyphrases

case control
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
hidradenitis suppurativa
patient reported outcomes